ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

The Inadequacy of the Current Standard of Care for Glioblastoma

David A. Reardon, MD
Published Online:10:12 AM, Tue November 29, 2016

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the inadequacy of the current standard of care in glioblastoma multiforme (GBM).
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.